SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SWOG | S1922-Small Bowel,Ram+Pac vs FOLFIRI, mets/unresect | 1 | Y | 1 Ramucirumab + Paclitaxel | 94 | 18 | 3 | 2 | 2 | 0 | 0 | 06/01/2020 | 145 | 53 |
2 FOLFIRI | 14 | 2 | 0 | 0 | 0 | 0 | ||||||||
32 | 5 | 2 | 2 | 0 | 0 | |||||||||
S2001-Rando II, Mets Pancreas , BRCA1/2, Comb Chemo | 1 | Y | 1 Olaparib + Pembrolizumab | 88 | 22 | 5 | 2 | 1 | 0 | 0 | 02/22/2021 | 192 | 75 | |
2 Olaparib | 25 | 10 | 3 | 0 | 0 | 0 | ||||||||
47 | 15 | 5 | 1 | 0 | 0 | |||||||||
S2104-Panc,Resect High-risk,Postop Adj Chemo vs Obs | 1 | Y | 1 Capecitabine Temozolomide | 154 | 26 | 17 | 10 | 4 | 3 | 2 | 05/05/2022 | 160 | 60 | |
2 Observation | 15 | 8 | 4 | 3 | 2 | 0 | ||||||||
41 | 25 | 14 | 7 | 5 | 2 | |||||||||
S2107-Colorectal, BRAF mut, Enc + CET +/-Nivo | 1 | Y | 1 Nivolumab + Encorafenib + Cetuximab | 84 | 37 | 25 | 15 | 8 | 3 | 0 | 07/19/2022 | 160 | 66 | |
2 Encorafenib Cetuximab | 22 | 12 | 5 | 2 | 1 | 0 | ||||||||
59 | 37 | 20 | 10 | 4 | 0 | |||||||||
Yes | A021806-Pancreas, Perioperative vs Adjuvant Chemo | 0 | E | Total Registrations | 35 | 10 | 4 | 1 | 0 | 0 | 10/08/2020 | 254 | 116 | |
35 | 10 | 4 | 1 | 0 | 0 | |||||||||
1 | E | Total Registrations | 29 | 9 | 5 | 1 | 0 | 0 | 10/08/2020 | |||||
29 | 9 | 5 | 1 | 0 | 0 | |||||||||
A022001-PANC, METS, Lu 177 Dotatate PRRT vs CAPTEM | 1 | E | Total Registrations | 2 | 2 | 1 | 0 | 0 | 0 | 06/08/2023 | 58 | 25 | ||
2 | 2 | 1 | 0 | 0 | 0 | |||||||||
A022004-Colon, Stg II-III, Encor+Cetux vs SOC | 0 | E | Total Registrations | 3 | 3 | 3 | 3 | 1 | 0 | 03/06/2024 | 2 | |||
3 | 3 | 3 | 3 | 1 | 0 | |||||||||
A022102-Gastric, FOLFIRINOX +/-Nivo vs FOLFOX +/ Nivo | 1 | E | Total Registrations | 10 | 10 | 6 | 5 | 2 | 1 | 05/15/2023 | 187 | 82 | ||
10 | 10 | 6 | 5 | 2 | 1 | |||||||||
A022104-Rectal, Loc Adv, Triplet vs Doublet Chemo | 1 | E | Total Registrations | 51 | 49 | 36 | 17 | 4 | 1 | 03/13/2023 | 320 | 126 | ||
51 | 49 | 36 | 17 | 4 | 1 | |||||||||
EA2174-Esoph, Peri-Op Nivolumab +/- Ipilimumab | 1 | E | Total Registrations | 6 | 0 | 0 | 0 | 0 | 0 | 06/01/2021 | 222 | 90 | ||
6 | 0 | 0 | 0 | 0 | 0 | |||||||||
2 | E | Total Registrations | 3 | 0 | 0 | 0 | 0 | 0 | 06/01/2021 | |||||
3 | 0 | 0 | 0 | 0 | 0 | |||||||||
EA2192-Panc, APOLLO | 0 | E | Total Registrations | 4 | 3 | 1 | 0 | 0 | 0 | 12/07/2022 | 145 | 84 | ||
4 | 3 | 1 | 0 | 0 | 0 | |||||||||
1 | E | Total Registrations | 2 | 2 | 1 | 0 | 0 | 0 | 12/07/2022 | |||||
2 | 2 | 1 | 0 | 0 | 0 | |||||||||
NRGGI008-Colon, Stg III, Adj Chemo | 1 | E | Total Registrations | 27 | 21 | 8 | 6 | 2 | 0 | 12/08/2022 | 408 | 171 | ||
27 | 21 | 8 | 6 | 2 | 0 | |||||||||
2 | E | Total Registrations | 17 | 14 | 5 | 3 | 2 | 0 | 12/08/2022 | |||||
17 | 14 | 5 | 3 | 2 | 0 | |||||||||
No | EA2176-Anal, Met, Immune Check Pt Inhibition + Chemo | 1 | E | Total Registrations | 28 | 11 | 6 | 4 | 3 | 1 | 08/09/2021 | 205 | 86 | |
28 | 11 | 6 | 4 | 3 | 1 | |||||||||
EA2182-Anal, Erly, DECREASE | 0 | E | Total Registrations | 12 | 6 | 0 | 0 | 0 | 0 | 05/04/2022 | 291 | 96 | ||
12 | 6 | 0 | 0 | 0 | 0 | |||||||||
1 | E | Total Registrations | 13 | 6 | 0 | 0 | 0 | 0 | 05/04/2022 | |||||
13 | 6 | 0 | 0 | 0 | 0 | |||||||||
EA2197-Gal, Rando Perioperative TX | 1 | E | Total Registrations | 5 | 3 | 1 | 0 | 0 | 0 | 11/18/2021 | 117 | 70 | ||
5 | 3 | 1 | 0 | 0 | 0 | |||||||||
NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy | 1 | Y | Total Registrations | 15 | 0 | 0 | 0 | 0 | 0 | 04/18/2018 | 318 | 114 | ||
15 | 0 | 0 | 0 | 0 | 0 | |||||||||
NRGGI005-COLON,Stg IIA, ctDNA in Adjuvant Chemotherapy | 1 | Y | Total Registrations | 35 | 2 | 0 | 0 | 0 | 0 | 07/06/2020 | 429 | 161 | ||
35 | 2 | 0 | 0 | 0 | 0 | |||||||||
Study | Registration/Phase | Open Date | # of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|
A022004 Colon, Stg II-III, Encor+Cetux vs SOC | 1 Registration | 30-May-23 | 2 | |
NRGGI008 Colon, Stg III, Adj Chemo | 3 Randomization | 10-Mar-22 | 408 | 171 |